Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
---|
03/06/2003 | WO2003018751A2 Apparatus and method for electroporation of biological samples |
03/06/2003 | WO2003018743A2 Emu-based formulations for wound treatment |
03/06/2003 | WO2003018730A1 Cosmetic composition comprising an essential oil extracted from helichrysum italicum |
03/06/2003 | WO2003018690A1 Composition containing fine particles for supporting biologically active substance thereon or having the same supported thereon and method for preparing these |
03/06/2003 | WO2003018639A1 Hyperbranched amylopectin for use in methods for surgical or therapeutic treatment of mammals or in diagnostic methods, especially for use as a plasma volume expander |
03/06/2003 | WO2003018597A1 POWDER COMPRISING WATER-CONTAINING β-MALTOSE CRYSTALS AND PRODUCTION PROCESS AND USE THEREOF |
03/06/2003 | WO2003018539A1 Amphoteric lipid compound and use thereof |
03/06/2003 | WO2003018186A1 Stable coated microcapsules |
03/06/2003 | WO2003018134A2 Bioadhesive compositions and methods for enhanced mucosal drug absorption |
03/06/2003 | WO2003018075A2 Transdermal therapeutic system with fentanyl or related substances |
03/06/2003 | WO2003018071A1 Transdermal therapeutic system (tts) with fentanyl as active ingredient |
03/06/2003 | WO2003018067A1 Contact agent for ultrasound diagnosis |
03/06/2003 | WO2003018065A1 Anti-cancer agents comprising disintegrin genes and the treating methods |
03/06/2003 | WO2003018064A2 Lipophilic drug compositions |
03/06/2003 | WO2003018063A1 Composition of a carrier substance for products based on papain and hyaluronidase |
03/06/2003 | WO2003018062A1 Improved therapeutic protocols |
03/06/2003 | WO2003018057A1 Remedy for glaucoma comprising as the active ingredient compound having pi3 kinase inhibitory effect |
03/06/2003 | WO2003018054A1 Helicobacter pylori vaccination |
03/06/2003 | WO2003018049A2 Use of milk serum apoproteins in the prophylaxis or treatment of microbial or viral infection |
03/06/2003 | WO2003018038A2 Composition for the treatment of varicose veins |
03/06/2003 | WO2003018034A1 Antacid and laxative tablets |
03/06/2003 | WO2003018033A1 Use of fucans in the treatment of adhesions, arthritis and psoriasis |
03/06/2003 | WO2003018028A1 Compositions comprising negatively charched phospholipids for treatment and/or prevention of macular degeneration and method for its manufacture |
03/06/2003 | WO2003018026A1 Use of estrogenic compounds in combination with progestogenic compounds in hormone-replacement therapy |
03/06/2003 | WO2003018023A1 Compositions and methods for targeting cerebral circulation and treatment of headache |
03/06/2003 | WO2003018018A2 Vinorelbine compositions and methods of use |
03/06/2003 | WO2003018015A1 Pharmaceutical composition for preventing drug abuse by pproducing musous membrane irritation |
03/06/2003 | WO2003018009A1 A combination of quetiapine and zolmitriptan |
03/06/2003 | WO2003017998A1 Platinum complexes and their use in cancer treatment |
03/06/2003 | WO2003017990A2 Ophthalmic composition comprising an ascomycin |
03/06/2003 | WO2003017989A1 Compositions and techniques for localized therapy of restenosis |
03/06/2003 | WO2003017988A1 Transdermal therapeutic system based on polyacrylate-contact-bonding adhesives without functional groups |
03/06/2003 | WO2003017987A1 Biodegradable polymeric nanocapsules and uses thereof |
03/06/2003 | WO2003017986A1 Compositions containing itraconazole and their preparation methods |
03/06/2003 | WO2003017985A1 Bilayered dispersible tablet formulation comprising amoxycillin and clavulanate in separate layers |
03/06/2003 | WO2003017984A1 A new extended release oral dosage form |
03/06/2003 | WO2003017983A1 A new extended release oral dosage form |
03/06/2003 | WO2003017982A1 A new extended release oral dosage form |
03/06/2003 | WO2003017981A1 Controlled release formulation of clarithromycin or tinidazol |
03/06/2003 | WO2003017980A1 Stable pharmaceutical compositions comprising acid labile benzimidazoles |
03/06/2003 | WO2003017979A1 Method for the production of inhalation powders |
03/06/2003 | WO2003017978A1 Method of manufacturing liposomes |
03/06/2003 | WO2003017977A1 Anaesthetic formulations of propofol |
03/06/2003 | WO2003017976A1 Synergistic mixed poloxamer systems for the solubilisation of drugs |
03/06/2003 | WO2003017974A1 Method of treating benign gynaecological disorders and a pharmaceutical kit for use in such method |
03/06/2003 | WO2003017973A1 A method of treating benign gynaecological disorders and a drug delivery vehicle for use in such a method |
03/06/2003 | WO2003017972A2 Multi-component polymeric systems with reverse thermal gelation behaviour (e.g. peo-ppo copolymers) |
03/06/2003 | WO2003017971A1 Drug delivery system |
03/06/2003 | WO2003017970A1 Spraying method for producing powder formulations |
03/06/2003 | WO2003017960A1 Oral rinse for treatment or prevention of bacterial and fungal infection |
03/06/2003 | WO2003017947A2 Spontaneous emulsions containing cyclosporine |
03/06/2003 | WO2003017941A2 Flexible applicator for applying oil-in-water emulsion with improved stability |
03/06/2003 | WO2003017940A2 Pulsatile release compositions and methods for enhanced gastrointestinal drug absorption |
03/06/2003 | WO2003017932A2 Compositions and methods for targeting cerebral circulation and treatment of headache |
03/06/2003 | WO2003017929A2 Method for treating bronchial constriction and bronchospasm |
03/06/2003 | WO2003017927A2 (-)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane, compositions thereof, and uses as a dopamine-reuptake inhibitor |
03/06/2003 | WO2003017921A2 A method to improve complexation efficacy and produce high-energy cyclodextrin-complexes |
03/06/2003 | WO2003017919A2 Composition comprising wenguanguo extracts, methods for preparing same and uses therof |
03/06/2003 | WO2003017818A2 Management of gastro-intestinal disorders |
03/06/2003 | WO2003000240A3 Stable powder inhalation dosage formulation |
03/06/2003 | WO2003000190A3 Liposomal encapsulation of glycosaminoglycans for the treatment of arthritic joints |
03/06/2003 | WO2002102356A3 Medicinal compositions comprising a melting core encapsulated in a hydroxypropylmethylcellulose film |
03/06/2003 | WO2002096367A3 Targeted multivalent macromolecules |
03/06/2003 | WO2002094219A3 Delivery of erectile dysfunction drugs through an inhalation route |
03/06/2003 | WO2002094218A3 Delivery of alprazolam, estazolam, midazolam or triazolam through an inhalation route |
03/06/2003 | WO2002085447A3 Microprojection array having a beneficial agent containing coating |
03/06/2003 | WO2002085446A3 Microprojection array immunization patch and method |
03/06/2003 | WO2002083129A3 Pharmaceutical composition comprising clavulanic acid |
03/06/2003 | WO2002074200B1 Formulations containing propofol and a sulfoalkyl ether cyclodextrin |
03/06/2003 | WO2002072064A3 Granular composition comprising an active compound and a cellulose ether and the use thereof |
03/06/2003 | WO2002070470A3 Benzophenones as inhibitors of reverse transcriptase |
03/06/2003 | WO2002065983A3 Hair covering with conditioner |
03/06/2003 | WO2002063961B1 Composition and methods for modulation of vascular structure and/or function |
03/06/2003 | WO2002060501A3 Hydrogel wound dressing,preparation and use thereof |
03/06/2003 | WO2002056867A3 Extended release pharmaceutical compositions containing beta-lactam antibiotics |
03/06/2003 | WO2002051383A3 Controlled release of anti-arrhythmic agents from a biodegradable polyethylene oxide hydrogel for local application to the heart |
03/06/2003 | WO2002041837A3 Treatment of mucositis |
03/06/2003 | WO2002028376A3 Chrono delivery formulations and method of use thereof |
03/06/2003 | WO2002022132A8 Novel topical oestroprogestational compositions with systemic effect |
03/06/2003 | WO2002017870A3 Clear antiperspirants and deodorants made with siloxane-based polyamides |
03/06/2003 | WO2001089483A9 Tablets and methods for modified release of hydrophilic and other active agents |
03/06/2003 | WO2001077988A3 System and method for rapidly customizing a design and remotely manufacturing biomedical devices using a computer system |
03/06/2003 | US20030045866 Method for convection enhanced delivery catheter to treat brain and other tumors |
03/06/2003 | US20030045865 Compositions and techniques for localized therapy |
03/06/2003 | US20030045829 Therapeutic agent delivery tampon |
03/06/2003 | US20030045742 Methods of synthesizing acylanilides including bicalutamide and derivatives thereof |
03/06/2003 | US20030045690 Having a mean diameter of 200-2000 nm, obtained by solidification from a mixture comprising fibrinogen, thrombin and Factor XIII in an water in oil emulsion |
03/06/2003 | US20030045678 Crystalline or crystal-like lipopeptide for use as bactericides |
03/06/2003 | US20030045597 Preparation and use of photopolymerized microparticles |
03/06/2003 | US20030045587 For solubilizing in a polar solvent an insoluble drug such as dantrolene or dilantin, comprising a sugar and/or C2-C3 di- or higher alcohol, and a second polar organic compound having an amide and/or an ammonium group, e.g. acetamide |
03/06/2003 | US20030045586 Use of amines |
03/06/2003 | US20030045583 Novel succinate salt of O-desmethyl-venlafaxine |
03/06/2003 | US20030045580 Making, by coating ibuprofen or its salt with hydroxypropylmethylcellulose, methylcellulose, sodium carboxymethylcellulose, hydroxypropylcellulose or gelatin as binder, in specified weight percents; dosage forms |
03/06/2003 | US20030045579 Compounds and compositions for delivering active agents |
03/06/2003 | US20030045577 Method for preventing infectious respiratory diseases |
03/06/2003 | US20030045567 (-)-1-(3,4-Dichlorophenyl)-3-azabicyclo[3.1.0]hexane, compositions thereof, and uses as a dopamine-reuptake inhibitor |
03/06/2003 | US20030045563 Comprises cyclooxygenase-2 inhibitors (celecoxib, rofecoxib); water solubility; vasodilation/headache relief; for inhibition of precipitation and/or crystallization in gastrointestinal fluids |
03/06/2003 | US20030045544 Bactericides for the oral region of animals using 3-carboxy-4-oxo quinoline or 1,8-naphthyridine derivatives or 1-cyclopropyl-3-carboyx-4-oxo quinolizine derivatives |
03/06/2003 | US20030045543 Systems and methods for treating a mucosal surface |
03/06/2003 | US20030045522 Novel galenical form for oral administration with prolonged release of molsidomine |